128 related articles for article (PubMed ID: 38364267)
21. Targeted drug-loaded PLGA-PCL microspheres for specific and localized treatment of triple negative breast cancer.
Nwazojie CC; Obayemi JD; Salifu AA; Borbor-Sawyer SM; Uzonwanne VO; Onyekanne CE; Akpan UM; Onwudiwe KC; Oparah JC; Odusanya OS; Soboyejo WO
J Mater Sci Mater Med; 2023 Aug; 34(8):41. PubMed ID: 37530973
[TBL] [Abstract][Full Text] [Related]
22. Redox-Sensitive Poly(lactic-
Dhamija P; Mehata AK; Tamang R; Bonlawar J; Vaishali ; Malik AK; Setia A; Kumar S; Challa RR; Koch B; Muthu MS
Mol Pharm; 2024 Jun; 21(6):2713-2726. PubMed ID: 38706253
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
[TBL] [Abstract][Full Text] [Related]
24. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
25. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
26. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
27. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy.
Deepika MS; Thangam R; Sheena TS; Vimala RTV; Sivasubramanian S; Jeganathan K; Thirumurugan R
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109716. PubMed ID: 31349431
[TBL] [Abstract][Full Text] [Related]
28. Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer.
Wang Z; Qin Y; Wang X; Zhang T; Hu Y; Wang D; Zhang L; Zhu Y
Int J Nanomedicine; 2023; 18():4023-4042. PubMed ID: 37520302
[TBL] [Abstract][Full Text] [Related]
29. Carnosic Acid Encapsulated in Albumin Nanoparticles Induces Apoptosis in Breast and Colorectal Cancer Cells.
Khella KF; Abd El Maksoud AI; Hassan A; Abdel-Ghany SE; Elsanhoty RM; Aladhadh MA; Abdel-Hakeem MA
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807348
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
[TBL] [Abstract][Full Text] [Related]
31. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
32. The Evaluation of Anti-Osteoclastic Activity of the Novel Calcium Hydroxide Biodegradable Nanoparticles as an Intracanal Medicament.
Promta P; Chaiyosang P; Panya A; Laorodphun P; Leelapornpisid W; Imerb N
J Endod; 2024 May; 50(5):667-673. PubMed ID: 38447912
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
[TBL] [Abstract][Full Text] [Related]
34. Novel Simvastatin-Loaded Nanoparticles Based on Cholic Acid-Core Star-Shaped PLGA for Breast Cancer Treatment.
Wu Y; Wang Z; Liu G; Zeng X; Wang X; Gao Y; Jiang L; Shi X; Tao W; Huang L; Mei L
J Biomed Nanotechnol; 2015 Jul; 11(7):1247-60. PubMed ID: 26307847
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
36. Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB
Kou L; Yao Q; Sivaprakasam S; Luo Q; Sun Y; Fu Q; He Z; Sun J; Ganapathy V
Drug Deliv; 2017 Nov; 24(1):1338-1349. PubMed ID: 28911246
[TBL] [Abstract][Full Text] [Related]
37. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
38. Clinical Advances in Triple Negative Breast Cancer Treatment: Focus on Poly (L-lactide-coglycolide) Nanoparticles.
Towner RA; Dissanayake R; Ahmed M
J Pharmacol Exp Ther; 2024 Jun; 390(1):53-64. PubMed ID: 38580448
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
